RecruitingNot ApplicableNCT07244757

Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control

Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control: A Randomized Controlled Trial


Sponsor

Cairo University

Enrollment

126 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

we aim to compare the analgesic efficacy of two intravenous ketorolac dosing regimens as part of a multimodal analgesic protocol that includes local wound infiltration for postoperative pain management after elective cesarean delivery.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ketorolac 15mg and a drug called Ketorolac 30 mg for people with ketorolac, cesarean delivery, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetorolac 30 mg

administered intravenously as 30 mg diluted in 10 mL of normal saline and injected over more than 15 seconds

DRUGKetorolac 15mg

administered intravenously as either 15 mg diluted in 10 mL of normal saline and injected over more than 15 seconds.


Locations(1)

Kasr Alainy Hospital

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07244757


Related Trials